Tag: World Health Organization
WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
For nonsevere COVID-19, 11th version of living guideline recommends against fluvoxamine (except in context of clinical trial), colchicine
WHO Says Monkeypox Not a Global Health Threat for Now
Committee said that while the outbreak is not yet a health emergency, that decision should be reviewed again in a few weeks
WHO Experts to Decide if Monkeypox Is a Global Emergency
Doing so would mean the WHO views the normally rare disease as a continuing threat to nations worldwide
Living Guideline Updated for Drug Treatment of COVID-19
Tenth version recommends nirmatrelvir/ritonavir in patients with confirmed COVID-19 who have highest risk for hospitalization
WHO: 99 Percent of Planet’s Population Breathes Dirty Air
Air quality is the worst in WHO Eastern Mediterranean and Southeast Asia regions
In Reversal, WHO Now Supports COVID-19 Boosters
Number of studies show that booster doses help restore weakening immunity and protect against severe COVID-19
Molnupiravir for Nonsevere COVID-19 Added to Living Guideline
Molnupiravir recommended only for those at highest risk for hospitalization given its potential long-term harms
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
Fewer than 10 percent of people in lower-income countries have received one dose of COVID-19 vaccine
WHO Living Guideline Updated for Drug Treatment of COVID-19
JAK inhibitor baricitinib strongly recommended for the treatment of severe or critical COVID-19
WHO Approves First Long-Acting Device to Shield Women From HIV
Vaginal ring made of silicone elastomer releases antiretroviral drug dapivirine into the vagina slowly over 28 days
